Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
862 Administration of intratumoral hu14.18-IL2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma
Compose a Response to This Article
Other responses
No responses have been published for this article.